Consequently, the development of more effective and less toxic antidepressant medications is imperative.292 Furthermore, the emerging focus among researchers on antidepressants that influence histone modifications, especially HDAC inhibitors, highlights a novel approach in the therapeutic landscape of MDD. This evidence concerns the gene HDAC9 and major depressive disorder.